|
FY2026
12 months to May 31, 2026
|
FY2025
12 months to May 31, 2025
|
FY2024
12 months to May 31, 2024
|
FY2023
12 months to May 31, 2023
|
FY2022
12 months to May 31, 2022
|
|
|---|---|---|---|---|---|
| Cash flows - operating activities: | |||||
| Net income (loss) | |||||
| Provision for losses on accounts receivable | |||||
| Provision for losses on inventory | |||||
| Provision for losses on royalty advances | |||||
| Amortization of prepublication costs | |||||
| Amortization of film and television programs | |||||
| Depreciation and amortization | |||||
| Amortization of net actuarial (gain) loss | |||||
| Deferred income taxes | |||||
| Stock-based compensation | |||||
| Income from equity method investments | |||||
| Loss on sale of investments | |||||
| Asset impairments and write downs | |||||
| Non cash write off related to assets held for sale | |||||
| Gain on sale and leaseback transactions | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Income tax receivable | |||||
| Tax credit receivable | |||||
| Prepaid expenses and other current assets | |||||
| Assets held for sale | |||||
| Investment in film and television programs | |||||
| Royalty advances | |||||
| Employee benefit plan contribution | |||||
| Accounts payable | |||||
| Accrued royalties | |||||
| Deferred revenue | |||||
| Other accrued expenses | |||||
| Accrued income taxes | |||||
| Liabilities related to assets held for sale | |||||
| Other, net | |||||
| Net cash provided by (used in) operating activities | |||||
| Cash flows - investing activities: | |||||
| Prepublication expenditures | |||||
| Additions to property, plant and equipment | |||||
| Proceeds from sale of assets | |||||
| Net proceeds from sale and leaseback transactions | |||||
| Proceeds from Sale of Equity Method Investments | |||||
| Proceeds from equity method investment, distribution, return of capital | |||||
| Acquisition-related payments | |||||
| Purchase of noncontrolling interests | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows - financing activities: | |||||
| Borrowings under lines of credit, credit agreement and revolving loan | |||||
| Repayments of lines of credit, credit agreement and revolving loan | |||||
| Borrowings under film related obligations | |||||
| Repayments of film related obligations (including interests) | |||||
| Repayment of capital lease obligations | |||||
| Reacquisition of common stock | |||||
| Proceeds pursuant to stock-based compensation plans | |||||
| Payment of dividends | |||||
| Other, net | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Cash paid for income taxes, net of refunds | |||||
| Cash paid for interest | |||||
Loading...